CB vs TRV: How Chubb Limited and The Travelers Companies Compare (2026)

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CB and TRV share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CB and TRV exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. It underwrites commercial and personal P&C insurance, accident and health coverage, reinsurance, and life insurance across roughly 54 countries, serving multinational corporations, businesses, and individuals. Its scale and worldwide network let it service large multinational accounts that smaller carriers cannot, which acts as a competitive barrier. The company is widely regarded for underwriting discipline, meaning it prioritizes writing profitable policies over chasing premium volume.

Full CB guide

The Travelers Companies, Inc. (NYSE: TRV) is a leading U.S. property and casualty insurer that provides commercial and personal insurance products and services to businesses, government units, associations, and individuals in the United States and selected international markets. It operates through three segments: Business Insurance (workers' compensation, commercial auto, general liability, commercial multi-peril, and related lines), Bond and Specialty Insurance (surety, fidelity, management liability, and professional indemnity), and Personal Insurance (homeowners and personal auto). The company distributes almost entirely through independent agents and brokers, collects premiums upfront, invests the float primarily in fixed-income securities, and earns underwriting profit when combined ratios stay below 100. Revenue for full-year 2025 was ~$48.8 billion, up ~5% year over year, and full-year net income was ~$6.3 billion. Investment income is a meaningful second earner: Travelers holds roughly 94% of its investment portfolio in fixed maturities and short-term instruments, and net investment income has been rising as higher-yielding bonds replace maturing lower-yielding paper.

Full TRV guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CB drivers: Underwriting discipline and margins; Rising investment income.
• TRV drivers: Underwriting Discipline Driving High Returns; Growing Investment Income as Rates Normalize at Higher Levels.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: As a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year. For TRV, the central bear case is catastrophe exposure: the January 2025 California wildfires alone generated ~$2.3 billion in pre-tax catastrophe losses in a single quarter, swamping what would otherwise have been strong underlying results.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CB if you believe its drivers more; TRV if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CB and TRV guides.

CB. Chubb reported record full-year 2025 net income of ~$10.31 billion (up ~11 percent) on revenue of ~$59.6 billion, with a record P&C combined ratio. The stock trades around ~12 to 13 times trailing earnings, a valuation broadly in line with large P&C peers. First-quarter 2026 net income was ~$2.32 billion, or ~$5.88 per share, benefiting from strong underwriting and investment income.

TRV. At roughly 9-10x trailing earnings, TRV trades well below its own 10-year historical average P/E of approximately 13x, reflecting in part the outsized catastrophe losses in early 2025 and broader insurance sector pressure. The ~2x price-to-book ratio is modest for a business generating core ROE near 19-20%, suggesting the market is pricing in meaningful ongoing catastrophe risk. Investors comparing Travelers to peers should note that insurance P/E ratios tend to fluctuate sharply around catastrophe quarters, making book value and ROE often more useful valuation anchors than a single year's earnings multiple.

Headline figures (approximate, JULY 2026): CB shows revenue (fy2025) ~$59.6 billion, net income (fy2025) ~$10.31 billion, diluted eps (fy2025) ~$25.68, market cap ~$124 billion; TRV shows revenue (full-year 2025) ~$48.8 billion, net income (full-year 2025) ~$6.3 billion, core return on equity (full-year 2025) ~19.4%, p/e ratio (ttm, as of jun 24, 2026) ~9.4x.

CB and TRV are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CB and TRV exposure against your real portfolio. It is not an investment adviser.